dismiss

Save the Date - Our next Clean Sweep Live Auction will be on Tuesday, September 26th at 9:30AM EST

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
>
> This Story

Forward Printable StoryPrint Comment

 

Oncology Homepage

DOSIsoft contouring and QA radiotherapy solutions selected by French public hospitals

Edinburgh Molecular Imaging commences phase II European cancer trial

Varian ranks first in overall Manufacturer, System, and Service Performance in 2017 survey of radiation oncology professionals

IBA releases the RAZOR Nano Chamber

Doctor Evidence to be subscription software platform for meeting abstracts for leading oncology association

Tumor ablation therapy market expected to surpass $1.2 billion by 2023

Elekta to highlight MOSAIQ Oncology Analytics for managing the oncology treatment pathway at ASTRO Annual Meeting

NELCO and OSL to partner on UK and Ireland projects

Varian to showcase latest technologies and software for advanced cancer care at ASTRO

Gastrointestinal stents market worth $472.5 million by 2025

Brachytherapy devices market to reach $383.7 million by 2022

Press releases may be edited for formatting or style
ALBANY, New York, September 14, 2017 /PRNewswire/ -- In the coming years, the Brachytherapy Device Market is expected to gain from biotechnological advancements in image guided procedures and dose delivery. Advent of 3D treatment planning is likely to enable physicians obtain results with better accuracy. This, coupled with the rising medical tourism, will enable the market exhibit positive growth in the coming years. Also, market players see significant prospects in the innovation of electronic brachytherapy devices, which constitute a novel technology. Such innovations are likely to open a plethora of opportunities offering lucrative growth prospects to the global brachytherapy market in the forthcoming years.

"Considering the rising incidence of cancer witnessed worldwide, the demand for brachytherapy devices is poised to surge in the coming years," said a lead TMR analyst. Driven by this and various other factors, the global brachytherapy market is forecast to reach US$383.7 mn by the end of 2022, from US$313 mn in 2017. If these figures hold true, the global brachytherapy devices market will rise at a moderate 4.2% CAGR between 2017 and 2022.

Story Continues Below Advertisement

Introducing HALCYON

We set out to rethink the way we approached radiotherapy, so you can redefine the way you fight cancer. Visit us at ASTRO booth #717. Click above to learn more



View Full Report at http://www.transparencymarketresearch.com/brachytherapy-devices-market.html

Among the various techniques the market offers, the Low Dose Rate held dominance with a share of 45.7% in the market in 2017. Regionally, North America is expected to show highly lucrative prospects, exhibiting a CAGR of 4.7% during the forecast period.

Brachytherapy Localizes Effect of Radiation, which is Fueling its Demand

Brachytherapy devices is a segment within the internal radiation therapy equipment market. In brachytherapy, the radiation source is sealed and placed near or inside the body part that may require radiation. Besides treating tumors, brachytherapy is used in the treatment of break, skin, cervix, and prostate cancer. In this technique, the source of radiation is sealed or enclosed within a protective capsule. Hence ionizing radiations escape to treat the cancerous tissues alone and without affecting body fluids.

Request to View Sample Report - http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=473

As healthcare providers and those ailing realize the benefits of brachytherapy over other radiation therapy equipment, the demand for the former will increase. Brachytherapy devices offer high precision in radiation. This in turn limits the effect of radiation only to the diseased or local parts of the anatomy affected by tumors or cancers. The process therefore protects healthier tissues against radiation. Against this backdrop, it can be said that the advent of brachytherapy has paved the way for a safer radiation therapies even in the presence of high and localized doses of radiation.
  Pages: 1 - 2 >>

Oncology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED